Helping Experts Accelerate Rare Treatments Act of 2021
Latest action · Feb 19, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 18, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Helping Experts Accelerate Rare Treatments Act of 2021
This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process.
The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as orphan drugs if the rarity of the disease makes it difficult for the drug to be profitable).
Cosponsors 9
Members who signed on, in the order they did. Signatures ran from Feb 18, 2021 to Sep 28, 2022, with 3 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-PA | Brian K. Fitzpatrick | Original | Feb 18, 2021 |
| R-WV | David B. McKinley | Original | Feb 18, 2021 |
| D-GU | Michael F. Q. San Nicolas | Original | Feb 18, 2021 |
| D-TX | Sheila Jackson Lee | Mar 9, 2021 | |
| D-FL | Alcee L. Hastings | Mar 17, 2021 | |
| D-FL | Stephanie N. Murphy | Apr 26, 2021 | |
| R-NY | Claudia Tenney | May 12, 2021 | |
| R-NE | Don Bacon | Feb 25, 2022 | |
| D-CA | Eric Swalwell | Sep 28, 2022 |
Actions 3
Everything that happened, newest first.
- Feb 19, 2021Referred to the Subcommittee on Health.
- Feb 18, 2021Introduced in House
- Feb 18, 2021Referred to the House Committee on Energy and Commerce.
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- European Union
- Government information and archives
- Government studies and investigations
- Health
- Health care coverage and access
- Health information and medical records
- Licensing and registrations
- Prescription drugs
Text 1
Each version as it was printed, newest first.
- Feb 18, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.